DarioHealth Corp. is a leading global digital therapeutics company revolutionizing the management of chronic conditions.

DarioHealth’s novel digital solutions platform empowers individuals managing pre-diabetes, diabetes, obesity, and hypertension to adjust their lifestyle and health choices to best manage their chronic condition. DarioHealth captures, monitors and communicates personalized health data and metrics to our users using precision data analytics to interpret their data and provide high quality digital and personalized coaching that help users make the best choices for their health.

The world leading Dario Blood Glucose Monitoring System has US FDA clearance and approval from the European CE, Health Canada, and Australia’s TGA. It is commercially available in the

United States, Canada, the United Kingdom, Germany, Italy, and Australia. DarioHealth is rapidly moving into new geographic markets and chronic conditions such as hypertension, stress management and obesity.

The Dario digital diabetes app is among the most downloaded and highest rated healthcare apps, with a 4.9/5.0 star rating and over 8,000+ reviews on the Apple store. Its Net Promoter Score (NPS), a measure of willingness of customers to recommend a company's products or services to others, is +77, considered "world class" and the highest in its category, on a -100 - +100 scale.

Our Cross Functional Team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions.